ANTY EXPO: Elux Showcases Open-System CYBEROVER P1, In-House E-Liquid Brand Yet to Debut in Malaysia

Events by 2FIRSTS
Sep.06.2024
ANTY EXPO: Elux Showcases Open-System CYBEROVER P1, In-House E-Liquid Brand Yet to Debut in Malaysia
ANTY EXPO opens in Malaysia showcasing e-cigarette innovations including CYBEROVER and CYBEROVER P1 by Elux.

On September 6, 2024, the Asia International New Tobacco Industry Expo (ANTY EXPO) officially opened at the Malaysia International Exhibition and Convention Centre (MIECC). As the official media partner of ANTY EXPO, the 2Firsts team has arrived at the exhibition site and set up a special interview room (booth number: H30) to provide industry professionals with first-hand market insights and trend analysis. Industry insiders are welcome to come and exchange industry news. According to 2Firsts, the well-known e-cigarette brand Elux is showcasing CYBEROVER and the open oil-infused product CYBEROVER P1 at the event. It is worth noting that CYBEROVER has already been launched in markets such as the United States this year.

 

ANTY EXPO: Elux Showcases Open-System CYBEROVER P1, In-House E-Liquid Brand Yet to Debut in Malaysia
CYBEROVER | Image source: 2Firsts

 

ANTY EXPO: Elux Showcases Open-System CYBEROVER P1, In-House E-Liquid Brand Yet to Debut in Malaysia
CYBEROVER Page 1 | Image source: 2Firsts

 

During the event, CYBEROVER P1 can be used with e-liquid. In addition, ELUX also showcased its own brand of e-liquid, but the booth staff stated that their e-liquid is not yet available on the market in Malaysia.

 

According to reports, the CYBEROVER P1 can accommodate three different pods (0.4Ω, 0.6Ω, 0.8Ω), while the refillable version CYBEROVER is equipped with dual heating coils.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

$200 Million Investment to Advance Smokeless Product Manufacturing at Reynolds
$200 Million Investment to Advance Smokeless Product Manufacturing at Reynolds
Reynolds American Inc. announced it will create 200 new manufacturing positions in 2026 at its Tobaccoville, North Carolina, Operations Center, bringing total new roles added over the past two years to more than 1,000. The company added 800 jobs between 2024 and 2025. These roles will support the continued growth of Velo Plus nicotine pouches and Reynolds’ expanding multi-category portfolio, aligned with its mission to build a smokeless world.
Dec.11 by 2FIRSTS.ai
Russia’s Perm Region Finalises Law Banning E-Cigarettes from March Next Year
Russia’s Perm Region Finalises Law Banning E-Cigarettes from March Next Year
The Governor of Russia’s Perm Region has confirmed that the newly adopted regional law banning vapes will take effect on March 1, 2026, despite lobbying from manufacturers and pressure from the federal level. The law prohibits the sale of all vaping products within the region, with penalties for violators, including fines for kiosks operating in residential areas.
Nov.26 by 2FIRSTS.ai
Al Fakher Parent Company Plans U.S. Listing in 2026 at $1.75 Billion Valuation
Al Fakher Parent Company Plans U.S. Listing in 2026 at $1.75 Billion Valuation
According to Bloomberg, Dubai-based hookah brand owner Advanced Inhalation Rituals (AIR) plans to go public on Nasdaq in the first half of 2026 through a merger with a Cantor Fitzgerald-backed SPAC. The deal values the combined company at USD 1.75 billion under the ticker “AIIR.”
Nov.11
BAT Podcast with AACS CEO: Vape Policy Imbalance Fuels Australia’s Billion-Dollar Illicit Market
BAT Podcast with AACS CEO: Vape Policy Imbalance Fuels Australia’s Billion-Dollar Illicit Market
In BAT’s The Smokeless Word podcast, AACS CEO Theo Foukkare warned that high taxes and strict vape bans have fueled Australia’s AUD 10-billion illicit nicotine market and rising retail crime, urging urgent regulatory reform.
Oct.27 by 2FIRSTS.ai
NYC Reaches Settlement with E-Cigarette Distributors in Flavored Vape Crackdown
NYC Reaches Settlement with E-Cigarette Distributors in Flavored Vape Crackdown
New York City has reached settlement agreements with two e-cigarette wholesalers accused of selling flavored vapes illegally. The companies agreed to stop all flavored vape transactions in the city and face $1,000 fines for future violations. Litigation against other defendants in the broader case continues.
Nov.25 by 2FIRSTS.ai
ceshi1111
ceshi1111
Trusted by industry leaders and innovators, ARAC brings unmatched expertise in Modules 5 & 6, including label and claim development, comprehension testing, human factors/usability, and clinical-behavioral research such as actual use and switching studies. These studies generate the robust, real-world evidence needed to evaluate whether products are “Appropriate for the Protection of Public Health” (APPH) -- including randomized experimental longitudinal, actual use, cohort st
Oct.21